Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 1,027 | 1,026 | 1,027 | 1,026 | 1,026 |
| Gross Profit | 1,027 | 1,026 | 1,027 | 1,026 | 1,026 |
| Operating Expenses | 20,632 | 15,080 | 13,271 | 11,366 | 10,596 |
| Operating Income | -19,605 | -14,054 | -12,244 | -10,340 | -9,570 |
| Interest Expense | 425 | 412 | 412 | 378 | 212 |
| Other Income | 376 | 331 | 159 | 34 | 137 |
| Pre-tax Income | -19,654 | -14,135 | -12,497 | -10,684 | -9,645 |
| Net Income Continuous | -19,654 | -14,135 | -12,497 | -10,684 | -9,645 |
| Net Income | $-19,654 | $-14,135 | $-12,497 | $-10,684 | $-9,645 |
| EPS Basic Total Ops | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 |
| EPS Basic Continuous Ops | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 |
| EPS Diluted Total Ops | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 |
| EPS Diluted Continuous Ops | -0.37 | -0.27 | -0.29 | -0.26 | -0.23 |
| EBITDA(a) | $-19,442 | $-13,824 | $-11,939 | $-10,084 | $-9,333 |